Protocol for Metagenomic Virus Detection in Clinical Specimens by Kohl, Claudia et al.
Sixty percent of emerging viruses have a zoonotic origin, 
making transmission from animals a major threat to public 
health. Prompt identification and analysis of these patho-
gens are indispensable to taking action toward prevention 
and protection of the affected population. We quantifiably 
compared classical and modern approaches of virus puri-
fication and enrichment in theory and experiments. Even-
tually, we established an unbiased protocol for detection 
of known and novel emerging viruses from organ tissues 
(tissue-based universal virus detection for viral metagenom-
ics [TUViD-VM]). The final TUViD-VM protocol was exten-
sively validated by using real-time PCR and next-generation 
sequencing. We could increase the amount of detectable 
virus nucleic acids and improved the detection of viruses 
<75,000-fold compared with other tested approaches. This 
TUViD-VM protocol can be used in metagenomic and vi-
rome studies to increase the likelihood of detecting viruses 
from any biological source.
Viruses responsible for disease outbreaks in humans naturally emerge either from the human population or 
as zoonoses by transmission from animal hosts (1). Viruses 
can also emerge unnaturally, either directly (e.g., bioter-
rorist attacks) or accidentally (e.g., laboratory infections). 
Despite these possibilities of virus emergence, 60% of 
emerging viruses have a zoonotic origin, thus highlighting 
transmission from animals to humans as a major threat to 
public health (2). Whenever viruses emerge, prompt iden-
tification of the agent and implementation of control mea-
sures to contain the outbreak are required.
Currently, various next-generation sequencing (NGS) 
approaches provide solutions for detection of purified and 
concentrated viruses (i.e., from cell culture). However, for 
clinical specimens, such as blood, other fluids, or infected 
organ tissues, successful detection of viruses is less likely 
because virus-to-host genome ratios are insufficient (3–6). 
Use of tissues from persons with suspected infections for 
virus detection enables elucidation of infection directly 
at the site of viral replication. Although detecting viruses 
directly from infected organ tissue provides obvious and 
valuable advantages, reliable purification of viruses direct-
ly from tissues still remains a challenge.
In this study, we quantifiably and extensively com-
pared classical and modern experimental approaches for 
virus purification and enrichment to finalize a protocol for 
unbiased detection of emerging viruses directly from or-
gan tissues (tissue-based unbiased virus detection for viral 
metagenomics [TUViD-VM]) for an increased signal-to-
noise ratio (ratio of virus genome to host genome) in vi-
rus detection. Use of this approach will reduce the amount 
of host nucleic acids required and save money and time in 
preparation of samples for NGS and the subsequent bioin-
formatic analysis.
Materials and Methods
We first describe how the protocol was developed and 
evaluated, We then describe the final virus purification and 
enrichment TUViD-VM protocol for metagenomic deep 
sequencing for nucleic acid from organ tissue (Figure 1).
Protocol Development
Ethics Statement
All procedures regarding the marmoset used in this study 
were performed in accordance with the European Asso-
ciation of Zoos and Aquaria Husbandry Guidelines for 
Callitrichidae, 2nd ed., 2010 (http://www.marmosetcare.
com/downloads/EAZA_HusbandryGuidelines.pdf), which 
promotes the highest possible standard for husbandry of 
zoo animals. The marmoset was kept in Zoo Heidelberg 
(Heidelberg, Germany) with other marmosets in a species-
appropriate environment enriched with material for occu-
pation and activity and adequate feeding regimens 3 times 
a day. The marmoset that was euthanized did not have any 
additional signs of illness or infection. The production of 
specific pathogen–free eggs (VALO BioMedia GmbH, 
Osterholz-Scharmbeck, Germany) was performed in 
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accordance with guidelines of the European Pharmaco-
poeia (EP7.0.5.2.2) and the US Department of Agriculture 
Veterinary Services (Memorandum 800.65).
All procedures regarding embryonated chicken eggs 
were based on German Animal Protection Laws. For infec-
tion, fertilized chicken eggs at embryonation day 11 were 
inoculated with virus into the allantois sack or onto the 
chorioallantoic membrane. Development of embryos was 
terminated at day 17 of embryonation by cooling the eggs 
overnight at 4°C. No further specific approval is needed for 
experiments on embryonated avians before time of hatch-
ing. However, additional approval from the internal ethics 
advisory board of the Robert Koch Institute was obtained 
and is available on request.
Study Design
To compare classical and modern experimental approaches 
of virus purification and enrichment, we designed a tissue 
model for internal organs of chicken, each infected with 1 
of 4 viruses (poxvirus [vaccinia virus], reovirus [orthoreo-
virus], orthomyxovirus [influenza virus], and paramyxovi-
rus [Sendai virus]) at low concentrations (Table 1; Table 
2, http://wwnc.cdc.gov/EID/article/21/1/14-0766-T2.htm; 
online Technical Appendix, http://wwnc.cdc.gov/EID/
article/21/1/14-0766-Techapp1.pdf). Viruses were chosen 
on the basis of their role in emerging zoonotic diseases and 
their morphologic and molecular heterogeneity to obtain 
results for a broad range of viruses (Table 3).
Model Tissue and Protocol Development
To establish a model tissue, we inoculated specific patho-
gen–free embryonated chicken eggs with 1 of the precho-
sen viruses at different concentrations. A detailed descrip-
tion of egg infection and preparation of the model tissue 
is shown in the online Technical Appendix. Reovirus (T3/
Bat/Germany/342/08) (11) was chosen to represent a non-
enveloped virus, orthomyxovirus (influenza A PR/8/1934) 
and paramyxovirus (Sendai virus) were chosen to represent 
enveloped viruses with an RNA genome, and poxvirus 
(vaccinia virus) was chosen to represent an enveloped virus 
with a DNA genome (Table 3). Viruses in this study were 
selected to optimize detection of viral zoonotic emerging 
diseases and possible virus bioterrorism agents.
To validate the model tissue homogeneity, we selected 
every ninth sample for simultaneous RNA/DNA extrac-
tion and determined copy numbers for all 4 viruses and the 
galTBP gene (Figure 2). Samples showed an even Gauss-
ian distribution of virus nucleic acids per aliquot and were 
considered suitable for subsequent experiments.
To establish a protocol for the purification and de-
tection of unknown viruses from animal tissue, we tested 
different purification techniques and their combinations, 
including mechanical, enzymatic, and molecular biologi-
cal methods; the main aim was to eliminate as much host 
DNA/RNA and maintain as much virus RNA/DNA as pos-
sible to optimize random PCR amplification of unknown 
viruses. The novel established protocol was tested to detect 
any virus from lung tissue derived from a New World mon-
key (marmoset), which had to be euthanized because of the 
unknown disease-causing agent.
We compared different techniques of virus purifica-
tion, enrichment, and amplification (detailed description of 
methods compared is shown in the online Technical Appen-
dix). In addition, complex purification techniques (diges-
tion and ultracentrifugation) were compared by conducting 
experiments that had specific control factors (e.g., ultracen-
trifugation with different concentrations of sucrose, time 
and speed) (12). Organization of combinations of different 
control factors and their variable factors (e.g., concentra-
tion levels, duration or speed in orthogonal assays) enables 
conducting a minimal number of experiments. On the ba-
sis of results of all purification techniques, we developed a 
combined protocol to provide the maximized yield of virus 
RNA/DNA after purification.
Validation and Analysis of Methods Compared
All compared methods were analyzed simultaneously. 
Because evaluation of sample quality was ongoing, to 
exclude any extraction bias, an additional unprocessed 
control aliquot was extracted and measured with every 
batch. All results of 1 extraction were rigorously com-
pared with a related control aliquot to normalize any 
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Figure 1. Schematic description of tissue-based universal virus 
detection for viral metagenomics protocol. Estimated durations 
of each step are shown in parentheses. The protocol takes 12 h 
to complete.
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variations caused by extraction, cDNA, and quantitative 
PCR (qPCR) performance.
Every result was evaluated for increasing the signal-to-
noise ratio of virus to host-genome (this ratio is indicated by 
). Given that Δ∆x =  Δ measured – Δ control, we assume that 
the ratio change between virus nucleic acids and host ge-
nome is given by ΔΔCt  = Δ purified – Δ unprocessed, where 
Ct is the cycle threshold. To visualize relative quantifica-
tion (RQ), RQ (2 – ΔΔCt) was plotted against the respective 
methods. The RQ value indicates the x-fold change com-
pared with that of the control aliquot (e.g., RQ value of 10 
means a 10-fold higher ∆ between virus and host genomes 
compared with the control aliquot) (13). Per definition of the 
RQ method, the area of significance lays outside RQ values 
of 0.5 and 2 if the samples show an even Gaussian distribu-
tion. Thus, results <0.5 and >2 were considered significant.
An additional scoring system was used to evaluate 
different methods. For every RQ result that increased the 
ratio between host and virus nucleic acids, we gave 1 point 
(maximum +4 points if the method led to better detectabil-
ity for all 4 viruses), and for every decrease, we subtracted 
1 point (minimum is subsequently –4 points). Methods 
with the highest scores were chosen for establishment of a 
combined protocol that included purification of unknown 
viruses from any tissue source (Table 1).
Final TUViD-VM Protocol for the Enrichment  
and Purification of Viruses from Organ Tissue
Tissue Homogenate
For homogenization, a small cube of tissue (0.5–1 cm3) 
was placed in an autoclaved screw-cap tube (Sarstedt, 
Hildesheim, Germany) containing 1 mL of phosphate-buff-
ered saline (PBS) buffer and 20–30 sterile ceramic beads. 
Tissue was disrupted by shaking 4 times at maximum speed 
at intervals of 15 s by using the FastPrep-24 Instrument 
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Table 1. Comparison of methods used to develop a protocol for metagenomic virus detection in infectious disease settings* 
Purpose, method and supplier Score† 
Virus release/homogenization  
 Ultrasonic (Sonopuls; Bandelin Electronic, Berlin, Germany) +2 
 Dounce homogenizer (Kleinfeld Labortechnik, Gehrden, Germany) +1 
 Qiashredder (QIAGEN, Hilden, Germany) 0 
 Trypsin (Life Technologies, Darmstadt, Germany) +3 
 FastPrep Homogenizer (MP Biomedicals, Strasbourg, France) (longer homogenization time) +4 
Enrichment of virus particles  
 Filtration 0.2- µm filter (Merck-Millipore, Temecula, CA, USA) +4 
 Filtration 0.45-µm filter (Merck-Millipore) 2 
 Fractionated filtration 1 
 Durapore polyvinylidene fluoride filter tubes (Merck-Millipore) +2 
 With or without clearing centrifugation +3 
 Taguchi-optimized centrifugation: 20% sucrose cushion overlaying 80% sucrose cushion and second clearing  
 ultracentrifugation 
+4 
 PEG-It virus precipitation (System Biosciences, Mountain View, CA, USA) +1 
 InRichment Virus Reagent Kit I (Analytik Jena AC, Jena, Germany) 1 
Digestion/removal of host nucleotides  
 Turbo DNA-free (Ambion, Darmstadt, Germany) 30 min at 37°C with centrifugation +4 
 RiboMinus Eukaryote Kit (Invitrogen Life Technologies, Grand Island, NY, USA) +1 
Nucleotide extraction  
 QIAamp UltraSens Virus Kit (QIAGEN) +2 
 QIAamp Viral RNA Mini Kit +2 
 PureLink Viral RNA/DNA (Invitrogen Life Technologies) +1 
 QIAamp MinElute Virus Spin Kit (QIAGEN) 1 
 RTP DNA/RNA Virus Mini Kit (Invitek, Berlin, Germany) 2 
 RTP DNA/RNA Virus Ultra Sense (Invitek) 0 
 NucleoSpin RNA II (Macherey Nagel, Dueren, Germany) 0 
 NucleoSpin DNA (Macherey Nagel) +2 
 Phenol chloroform extraction (Carl Roth GmbH, Karlsruhe, Germany) +3 
 TRIzol LS reagent (Life Technologies) +4 
Amplification  
 N12 random primer +3 
 N10 random primer +2 
 WTA‡ +3 
 WGA 0 
 K primer‡ (7) +3 
 3locked random primer (8) +1 
*WTA, whole transcriptome amplification; WGA, whole genome amplification. 
†For every relative quantification result that increased the ratio between host and virus nucleic acids, 1 point was assigned (maximum +4 points if the 
method led to a better detectability for all 4 viruses). For every decrease, 1 point was subtracted (minimum 4 points). 
‡WTA and K primer showed similar results. However, when we considered the lower costs and ease of handling of K primers,  
we used K primers for this protocol. 
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(MP Biomedicals, Strasbourg, France). The duration of this 
procedure was ≈0.5 h.
Clearing Centrifugation
A total of 200 mL of homogenate was placed in a 1.5-mL 
tube and vortexed vigorously. The homogenate was cen-
trifuged for 5 min at 2,000 rpm in a bench top centrifuge 
(Eppendorf, Hamburg, Germany). The supernatant (≈170 
mL) was transferred into a clean tube, and the pellet was 
discarded. The duration of this procedure was ≈0.25 h.
Ultracentrifugation for Virus Particle Separation
A total of 250 mL of 80% (wt/vol) sucrose solution was 
pipetted into a 2 3/8-in PA ultracentrifuge tube (Beckman 
Coulter, Krefeld, Germany) and gently overlayed with ≈3 
mL of 20% (wt/vol) sucrose solution. The visibility of the 
phase interface between the 80% and 20% sucrose solu-
tions was checked. The sucrose solution was gently over-
layed with cleared tissue supernatant, and PBS was then 
added to the tubes. The tubes were centrifuged in an SW60 
rotor (Beckman Coulter) at 30,000 rpm for 2 h at 4°C. The 
duration of this procedure was ≈2 h.
Ultracentrifugation to Pellet Virus Particles
The layer on the interface between the 20% and 80% 
sucrose solutions was collected and transferred into a 
3 1/2-intube (suitable for Beckmann SW32Ti rotors; Beck-
man Coulter). The collected layer was resuspended in ≈40 
mL of PBS and mixed gently by pipetting up and down. 
The suspension was centrifuged for 1 h at 20,000 rpm and 
4°C. The supernatant was then discarded. The duration of 
this procedure was ≈1 h. As an alternative method, virus 
particles can be precipitated overnight by using Peg-It 
(System Biosciences, Mountain View, CA, USA).
DNA Digestion
The pellet was resuspended in 245 mL of 1× digestion buf-
fer (Turbo DNA Free Kit; Ambion, Darmstadt, Germany). 
A total of Add 5 mL of Turbo DNase (Turbo DNA Free 
Kit: Ambion) was added and incubated for 30 min at 37°C. 
The suspension was transferred to a 1.5-mL reaction tube. 
A total of 10 mL of stop reagent (Turbo DNA Free Kit; 
Ambion) wad added, incubated at room temperature for 1 
min, and centrifuged at 2,000 rpm for 3 min. The super-
natant was transferred to another tube, and pellet was dis-
carded. The duration of this procedure was ≈0.75 h.
Combined TRIzol LS Extraction
A total of 750 mL of TRIzol LS (Invitrogen Life Tech-
nologies, Grand Island, NY, USA) was added to ≈250 mL 
of supernatant from previous procedures and homogenized 
by pipetting up and down 10 times. The mixture was in-
cubated for 5 min at room temperature and centrifuged at 
12,000 rpm for 10 min. The supernatant was transferred to 
precentrifuged phase-lock gel tube (5-Prime, Hilden, Ger-
many). A total of 200 mL of chloroform–isoamyl alcohol 
was added and mixed by inverting the tube vigorously. The 
tube was incubated for 15 min at room temperature and 
centrifuged at 12,000 rpm for 15 min.
Approximately 280 mL of supernatant from the phase-
lock gel tube was transferred to another tube containing 
1,120 mL of AVL lysis buffer without carrier RNA (Viral 
RNA Mini Kit; QIAGEN, Hilden, Germany). A total of 
700 mL of absolute ethanol was added and mixed by pulse 
vortexing. The solution was transferred in 600-mL portions 
to a QIAamp Mini Column, QIAGEN), centrifuged 8,000 
rpm for 1 min, and the filtrate was discard. The column was 
placed in a new collection tube, loaded again, and centri-
fuged until the lysate was added to the column. A total of 
500 mL of 70% (wt/vol) ethanol was added and the column 
was centrifuged at 8,000 rpm for 3 min.
A mixture of 10 mL of DNase and 70 µL of RDD buf-
fer (RNase-Free DNase Set; QIAGEN) was added to the 
column and incubated for 15 min at room temperature, as 
described by the manufacturer. The column was washed 
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Table 3. Properties of 4 viruses used to develop a protocol for metagenomic virus detection in infectious disease settings* 
Property Reovirinae, reovirus 
Orthomyxovirinae, influenza 
virus A 








Buoyant density, g/mL 1.36 1.2 1.23–1.27 1.31 
Size genome, kbp 23.5 13.5 186–192 15.5 
RNA/DNA dsRNA (–) ssRNA dsDNA (–) ssRNA 
Genome organization Linear, 10 segments Linear, 8 segments Linear, continuous Linear, continuous 
Envelope No Yes Yes Yes 
Replication Cytoplasm Nucleus Cytoplasm Cytoplasm 
Virion assembly Cytoplasmic inclusion 
bodies (viral factories) 
Cytoplasm Cytoplasmic factory 
areas 
Cytoplasm 
Release After virus-induced 
cell death 
Budding from cell membrane Exocytosis, cell lysis Budding from cell 
membrane 
Sensitivity Unknown Cesium chloride, heat, 
formaldehyde, SDS, ultraviolet 
light, oxidation compound 
Unknown Cesium chloride, heat, 
formaldehyde, SDS, 
oxidation compound 
*Virus data were obtained from King et al. (9) and Tidona and Darai (10). –, negative. SDS, sodium dodecyl sulfate. 
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with 500 mL of AW1 buffer, centrifuged at 8,000 rpm for 1 
min, and the filtrate was discarded. The column was placed 
in a new tube, 500 mL of AW2 buffer was added, the tube 
was centrifuged at maximum speed for 3 min, and the fil-
trate was discarded. The column was then placed in a new 
tube, and the tube was centrifuged at maximum speed for 
1 min to dry the column. A total of 30 mL of elution buf-
fer was added to the column, incubated for 5 min at room 
temperature, and the column was centrifuged in a new 1.5-
mL tube. A total of 30 mL of elution buffer was added to 
the column, incubated for 5 min at room temperature, and 
centrifuged in the same tube. RNA (≈60 mL) was chilled 
on ice. The duration of this procedure was ≈3 h.
Random Amplification
Single-stranded cDNA was produced by using the Re-
verse Transcription Reagent Kit (Applied Biosystems, 
Foster City, CA, USA) and adapted for a 50-mL  reac-
tion containing 30 mL  of RNA, 2 mL (40 µmol/L) of 
K8N random primer (7), 3.2 mL (25 mmol/L) of dNTPs, 
4 mL 10×  buffer, 9 mL (50 mmol/L) of MgCl2, 0.8 mL 
of RNase inhibitor, 0.6 mL of reverse transcriptase, and 
0.4 mL of water). A total of 2 mL of K8N random primers 
and 3.2 mL of dNTPs were added to the 30 mL of RNA 
and heated at 95°C for 5 min before quenching on ice. The 
remaining contents of the mixture were heated at 42°C 
for 60 min before the enzyme was inactivated at 95°C for 
10 min.
Double-stranded cDNA was produced by mixing 2 
mL of K8N random primers, 3 mL of Klenow buffer (New 
England Biolabs, Ipswich, MA, USA), and 2 mL (2.5 
mmol/L) of dNTPs with 19 mL of cDNA. The mixture was 
heated at 95°C for 2 min and cooled to 4°C. A total of 1.67 
mL of Klenow fragment (New England Biolabs) was added 
and the mixture was at 37°C for 60 min. Double-stranded 
cDNA was purified by using the MSB Spin PCRapace 
Purification Kit (Invitek, Berlin, Germany) and an elution 
volume of 30 mL. Random amplification was performed 
by using the procedures reported by Stang and Korn (7). 
Successful random amplification (a 200–2,000-bp smear) 
was visualized by agarose gel electrophoresis of 10 mL of 
PCR product. The duration of this procedure was ≈4.5 h. 
Sequence information can be obtained by either cloning 
into sequencing vectors or by NGS.
NGS
RNA samples were fragmented by using the NEBNext 
Magnesium RNA Fragmentation Module (New England 
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Figure 2. Validation of test aliquots of infected mode used for 
development of tissue-based universal virus detection for viral 
metagenomics protocol. Every ninth aliquot was extracted, and 
viral copy numbers were determined by using a quantitative PCR. 
SDs (error bars), medians (solid horizontal lines), and residual 
plots indicate homogeneity and mixture of test specimens. Ct, 
cycle threshold.
Figure 3. Comparison of tissue homogenization methods used 
for development of tissue-based universal virus detection for 
viral metagenomics protocol. Copy numbers were measured by 
quantitative PCR in duplicate. RQ, relative quantification: RQ 
(2 – ΔΔCt); (ΔΔCt = Δ purified – Δ unprocessed). Lower panel left 
y-axis indicates signal-to-noise ratio (RQ) for all viruses tested. 
The method with the highest score was used to establish the 
protocol and is shaded in yellow. Red stars indicate highest 
scores. Diagonally striped area indicates not significant. Ct, cycle 
threshold. Numbers along baseline indicate method used:  
1, control; 2, Dounce homogenizer; 3, extended homogenization; 
4, trypsin; 5, ultrasound; 6, QIAshredder (QIAGEN,  
Hilden, Germany).
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Biolabs). RNA was purified by using RNeasy MinElute 
(QIAGEN). For cDNA synthesis, Superscript II and 
Murine RNAse inhibitor (New England Biolabs) were 
used. Second-strand synthesis was performed by using the 
NEBNext mRNA Second Strand Synthesis Module (New 
England Biolabs) and purified by using the MinElute PCR 
Purification Kit (QIAGEN).
Double-stranded cDNA, DNA, and random PCR 
products were quantified by using the Qubit HS dsDNA 
Kit (Invitrogen Life Technologies). Sequencing libraries 
were established by Ion Xpress Plus Fragment Library Kit 
(without chemical fragmentation) with indices (Ion Xpress 
Barcode Adapters 1–16 Kit). The sequencing library was 
then amplified by using an emulsion-based clonal ampli-
fication PCR in the Ion OneTouch 200 Template v2 DL 
Kit and enriched by using an Ion OneTouch Enrichment 
System. Sequencing was performed on an IonTorrent PGM 
in the Ion PGM Sequencing 300 Kit with the Ion 318 Chip 
Kit (Invitrogen Life Technologies).
NGS Data Analysis
Programs used for sequence analysis were Geneious 
Pro R6 (Biomatters, Auckland, New Zealand) and Bow-
tie2align (14). The percentage of bases (Q>20) was ≈80% 
before length filtering (100–1,000 nt) was applied to re-
move shorter reads. No additional quality trimming was 
applied because the quality average was sufficient for our 
approach. Remaining reads were mapped to the whole ref-
erence genomes (or all segments of reference genome) by 
using Bowtie2align for paramyxovirus (Sendai virus strain 
Tianjin; GenBank accession no.  EF679198), reovirus (T3/
Bat/Germany/342/08, 10 segments; JQ412755-JQ412764), 
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Figure 4. Comparison of filtration methods used for development 
of tissue-based universal virus detection for viral metagenomics 
protocol. Copy numbers were measured by quantitative PCR 
in duplicate. RQ, relative quantification: RQ (2 – ΔΔCt); (ΔΔCt 
= Δ purified – Δ unprocessed). Lower panel left y-axis indicates 
signal-to-noise ratio (RQ) for all viruses tested. The method 
with the highest score was used to establish the protocol and is 
shaded in yellow. Red stars indicate highest scores. Diagonally 
striped area indicates not significant. Ct, cycle threshold. Numbers 
along baseline indicate method used: 1, control; 2, 0.22-μm filter; 
3, 0.45-μm filter; 4, filter extraction 1; 5, filter extraction 2; 6, 
fractionated filtration; 7, filter tubes.
Figure 5. Comparison of enrichment methods used for development 
of tissue-based universal virus detection for viral metagenomics 
protocol. Copy numbers were measured by quantitative PCR in 
duplicate. RQ, relative quantification: RQ (2 – ΔΔCt); (ΔΔCt = Δ 
purified – Δ unprocessed). Lower panel left y-axis indicates signal-to-
noise ratio (RQ) for all viruses tested. The method with the highest 
score was used to establish the protocol and is shaded in yellow. 
Red stars indicate highest scores. Diagonally striped area indicates 
not significant. Ct, cycle threshold. Numbers along baseline indicate 
method used: 1, control; 2, PEG-It (System Biosciences, Mountain 
View, CA, USA); 3, InRichment Virus Reagent Kit (Analytik Jena AC, 
Jena, Germany); 4, clearing centrifugation; 5, clearing centrifugation 
at 25,000 rpm for 2 h; 6, second clearing centrifugation after 20% 
sucrose centrifugation; 7, tissue enrichment; 8, Ribominus Eukaryote 
Kit (Life Technologies, Grand Island, NY, USA).
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orthomyxovirus (influenza H1N1 strain A/Puerto Rico 
8-SV14/1934, 8 segments; CY040170-CY040177), and 
poxvirus (vaccinia virus strain WR, no. AY243312). Cov-




Every step of the TUViD protocol (homogenization of tis-
sue, filtration, digestion, enrichment, extraction, and random 
amplification) was compared with alternative approaches. 
Results are shown in Figures 3–7. Each approach was tested 
with individual samples, which were measured by using 5 
PCRs specific for viruses used and host background in 2 
replicates (10 reactions/sample): Results were quantified 
and evaluated in qPCRs for the 4 viruses and presence of 
host nucleic acids (online Technical Appendix; Table 4, 
http://wwwnc.cdc.gov/EID/article/21/1/14-0766-T4.htm; 
Figures 3–7). A scoring system was developed to assess the 
optimal combination of all 4 viruses (Table 1; Figures 3–7). 
A preliminary protocol was further validated and adjusted 
until no host nucleic acids were detectable by qPCR. This 
protocol maximized the amount of amplified virus nucleic 
acids. Subsequently, we established an unbiased protocol for 
the detection of known and novel viruses in infected organ 
tissues (TUViD-VM).
TUViD-VM Validation by NGS
The TUViD-VM protocol was validated by NGS of 4 ali-
quots of the model tissue. One aliquot was prepared by 
using the TUViD-VM protocol developed in this study, 
and 3 aliquots were prepared by using other approaches 
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Figure 6. Comparison of extraction methods used for development 
of tissue-based universal virus detection for viral metagenomics 
protocol. Copy numbers were measured by quantitative PCR in 
duplicate. RQ, relative quantification: RQ (2 – ΔΔCt); (ΔΔCt = Δ 
purified – Δ unprocessed). Lower panel left y-axis indicates signal-
to-noise ratio (RQ) for all viruses tested. The method with the 
highest score was used to establish the protocol and is shaded 
in yellow. Red stars indicate highest scores. Diagonally striped 
area indicates not significant. Ct, cycle threshold. Numbers along 
baseline indicate method used: 1, Nucleospin RNA II (Macherey 
Nagel, Dueren, Germany); 2, Nucleospin DNA (Macherey Nagel); 
3, RTP DNA/RNA Virus Ultra Sense (Invitek, Berlin Germany); 
4, RTP DNA/RNA Virus Mini Kit (Invitek); 5, QIAmp UltraSens 
Virus Kit (QIAGEN, Hilden, Germany); 6, QIAamp Viral RNA Mini 
Kit (QIAGEN); 7, QIAmp MinElute Virus Spin Kit (QIAGEN); 8, 
PureLink Viral RNA/DNA (Invitrogen Life Technologies, Grand 
Island, NY, USA); 9, TRIzol LS; 10, phenol chloroform.
Figure 7. Comparison of primers and random amplification 
methods used for development of tissue-based universal virus 
detection for viral metagenomics protocol. Copy numbers 
were measured by quantitative PCR in duplicate. RQ, 
relative quantification: RQ (2 – ΔΔCt); (ΔΔCt = Δ purified – Δ 
unprocessed). Lower panel left y-axis indicates signal-to-noise 
ratio (RQ) for all viruses tested. The method with the highest 
score was used to establish the protocol and is shaded in yellow. 
Red stars indicate highest scores. Diagonally striped area 
indicates not significant. Ct, cycle threshold. Numbers along 
baseline indicate method used: 1, control; 2, K primer; 3, 3′ 
locked primer; 4, N12 primer; 5, N primer; 6, whole transcriptome 
amplification (QIAGEN, Hilden, Germany); 7, whole genome 
amplification (QIAGEN).
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commonly used for unbiased virus detection (Figure 8; 
online Technical Appendix). We chose the Invitrogen 
Life Technologies platform because of its rapid run time 
and read length, which are crucial for diagnostic purpos-
es. All independent runs were normalized to 1,000,000 
output reads for reliable comparison (Table 5; Figure 8). 
NGS results confirmed the substantial increase in virus 
nucleic acids, as well as the decrease of host nucleic ac-
ids achieved by purification with the novel protocol. The 
amount of detectable virus nucleic acids was increased 
>1,000-fold compared with other NGS approaches (Fig-
ure 8). For example, although the best NGS approach de-
livered 40 reads for paramyxovirus in infected chicken 
tissue, the TUViD-VM protocol resulted in >60,000 reads 
(97.80%  coverage of the complete genome) (Figure 8; 
Figure 9, http://wwwnc.cdc/gov/EID/article/21/1/14-
0766-F9.htm; Figure 10, http://wwwnc.cdc/gov/EID/
article/21/1/14-0766-F10.htm; Table 5).
To provide a proof of concept, we prepared lung tis-
sue from the marmoset that was euthanized and had a nat-
ural respiratory infection with Sendai virus by using the 
4 approaches and sequenced by using the Invitrogen Life 
Technologies protocol. Using the TUViD-VM protocol, 
we found that the amount of detectable virus in marmoset 
tissue  increased 75,000-fold compared with that for other 
NGS approaches (>400,000 Sendai virus reads compared 
with 6), which represented 99.98% coverage of the Sendai 
virus genome and ≈50% of the total read output (Figures 
8, 10; Table 5).
Discussion
In this study, we successfully established a purification 
and enrichment protocol, which shows rapid and reliable 
results, for detection of known and novel viruses in tissues. 
Likelihood of detection of RNA viruses was increased. In 
addition, detection of DNA incorporated in virus particles 
was not affected even though DNA digestion was per-
formed. The cutoff sensitivity was 100–1,000 virus copies/
mL of homogenized organ material (e.g., reovirus; Table 
5). The cutoff sensitivity of compared approaches was ≥106 
virus copies/mL. The TUViD-VM protocol (from solid tis-
sue sampling to nucleic acid preparation for NGS) takes 12 
h to complete. If one allows 16 h for NGS, the TUViD-VM 
protocol provides sequence data output within 28 h.
Current NGS techniques used for metagenomic ap-
proaches produce large amounts of sequence data, which 
might increase the likelihood of detection of diminutive 
amounts of virus in comparison with the host genome. 
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Figure 8. Results of comparative next-generation sequencing used for development of tissue tissue-based universal virus detection 
for viral metagenomics (TUViD-VM) protocol. A) Sample preparation flowchart to generate 4 next-generation sequencing approaches. 
B) Results obtained for model tissue (chicken) infected with 4 viruses: vaccinia virus (poxvirus) Sendai virus (paramyxovirus), 
influenza virus (A/PR8/1934), or reovirus (T3/Bat/G/342/08). The baseline is log-scaled, and normalized read numbers are indicated. 
C) Results of marmoset sample proof of principle, Sendai virus–infected lung tissue. The baseline is log-scaled, and normalized read 
numbers are indicated.
RESEARCH
The only limiting factor seems to be the cost required 
for processing 1 sample and capacities for computational 
analysis of results. This in silico analysis should increase 
the signal-to-noise ratio of relevant sequences by sub-
tracting nonrelevant sequences, such as the host genome. 
However, genome sequence data for mammals are lim-
ited; only 23 sequences (0.4%) for 5,487 species (18). Just 
3 genome sequences are available for bats, although they 
are the second most abundant mammalian species (ex-
ceeded only by rodents). There are >1,100 species of bats 
worldwide and they are suspected vectors of pathogenic 
viruses (e.g., Ebola virus, Nipah virus, Hendra virus, lys-
savirus, and severe acute respiratory syndrome coronavi-
rus). Thus, it seems inefficient to invest large amounts of 
time, money, and effort in obtaining large datasets, only 
to invest even more resources to categorize them. Further-
more, quantitative comparison of the virus-enrichment 
strategies described enables evaluation of multiple classi-
cal and modern approaches.
The TUViD-VM described protocol increases the sig-
nal-to-noise ratio by as much as 75,000-fold than that for 
compared approaches and can detect virus genomes quick-
ly in infected tissues (Figures 9, 10). Although sequenc-
ing of nucleic acid from relatively pure sources (e.g., cell 
culture, allantoic fluids) is well established and results in 
reasonable output (11,19,20), sequencing of nucleic acid 
clinical specimens is still challenging. Other studies re-
ported 0.1% to <10% mammalian virus reads from clinical 
samples, such as tissue, guano, feces, and pharyngeal swab 
specimens (3,19,21–24). A method reported by Daly at al. 
showed promising results for detection of DNA viruses but 
lacked similar results for detection of RNA viruses (25). 
In contrast, our protocol resulted in up to 45% mamma-
lian RNA virus reads directly from infected organ tissue 
(Figure 8).
After its successful and extensive validation, we 
highly recommend this protocol for investigation of out-
breaks with unknown viral etiologic agents in humans 
and animals. Furthermore, this protocol can be used in 
metagenomic virome studies and will be beneficial when-
ever library construction is necessary (i.e., molecular 
cloning and NGS) to increase detection likelihood for 
viruses from any biological source. This protocol would 
be particularly useful for increasing the signal-to-noise 
ratio in virus analysis of biological samples in which 
levels of background nucleic acids are high, which result 
in difficulties in virus detection and identification. Thus, 
the TUViD-VM protocol described greatly increases the 
likelihood of detecting viruses during outbreaks of emerg-
ing infectious diseases and in metagenomic virus detec-
tion studies.
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